One is a grant. The other is a tax credit. Together, they recover over 60% of your R&D costs. This guide gives you the real numbers, the real timelines, and the definitive recommendation for your business type.
IRAP is a non-repayable grant from the National Research Council. You apply before starting work, get assigned an Industrial Technology Advisor, and receive milestone-based reimbursements covering up to 80% of salary costs. Typical awards are ~$500K, though first-timers usually get $75K-$200K. It requires pre-approval and only covers future work.
SR&ED is a tax credit administered by the CRA. You perform R&D work, document it, and claim up to 35% back (enhanced rate for CCPCs on the first $6M, after Budget 2025) when you file your corporate tax return. It is retrospective — you can claim up to 18 months after your fiscal year-end with no pre-approval required. Provincial credits add 8% to 25% on top.
They are not mutually exclusive. You should apply for both. IRAP covers upfront costs. SR&ED recovers your co-investment after the fact. Combined, they can offset over 60% of total R&D costs.
Clear recommendations by business situation — no hedging.
The single best option for a pre-revenue tech startup is IRAP, not SR&ED.
IRAP provides upfront cash flow when you have no revenue to offset tax credits against. The 35% SR&ED enhanced rate is refundable for CCPCs regardless of revenue, but IRAP also assigns a dedicated Industrial Technology Advisor who provides strategic guidance worth more than the money itself for an early-stage company. Apply for IRAP first, then stack SR&ED on top.
For an established manufacturer spending $1M+ annually on R&D, SR&ED delivers more total dollars than IRAP.
At $1M in eligible R&D spend, the SR&ED enhanced rate returns $350,000 in refundable credits. IRAP's typical contribution of ~$500K on a single project is comparable, but SR&ED has no application process, no advisor meetings, and no milestone reporting. For companies with strong documentation practices and large recurring R&D budgets, SR&ED is the lower-friction, higher-ceiling program. Budget 2025 doubled the enhanced rate threshold from $3M to $6M, making SR&ED even more valuable at scale.
Software companies should claim SR&ED on every project and layer IRAP on top of the most ambitious ones.
Software development often involves the kind of technological uncertainty SR&ED rewards (novel algorithms, performance breakthroughs, integration challenges). Most software companies underestimate what qualifies. IRAP is harder to get for pure software because NRC favours projects with clear hardware/IP components, though the AI Assist stream ($100M over 5 years) has changed this for AI-focused companies.
Stop asking "which one should I pick?" The correct answer for 90% of incorporated Canadian SMEs doing genuine R&D is: apply for both programs simultaneously. They are complementary by design. The following sections explain exactly how each works and how to stack them.
Every dimension that matters, side by side. 17 factors compared.
| Dimension | IRAP | SR&ED |
|---|---|---|
| Funding type | Non-repayable grant (contribution) | Refundable tax credit (ITC) |
| Administered by | National Research Council (NRC) | Canada Revenue Agency (CRA) |
| Annual budget | ~$512M (FY2024-25, incl. SDTC absorption) | ~$4.5B in ITC allowed annually |
| Maximum amount | Up to $10M (typical ~$500K) | No cap (35% enhanced on first $6M expenditure; 15% on excess) |
| Typical first-time amount | $75K – $200K | $30K – $150K (depends on R&D spend) |
| Eligible entities | Incorporated Canadian SMEs, <500 FTEs | Any Canadian taxpayer performing R&D (CCPCs get enhanced rate) |
| Pre-approval required? | Yes — must be approved before work begins | No — claim retroactively up to 18 months post fiscal year-end |
| When you get paid | Monthly milestone reimbursements during the project | 60-120 days after filing annual tax return (can be 6-12 months if reviewed) |
| Advisory support | Yes — dedicated Industrial Technology Advisor | No — purely financial, no advisory component |
| Eligible costs | Salaries (80%), subcontractors (50%) | Salaries, materials, subcontractors (80%), overhead, capital equipment (Budget 2025) |
| Retroactive claims | No — only future work after approval | Yes — up to 18 months after fiscal year-end |
| Application effort | High — ITA meetings, formal proposal, milestones | Moderate — Form T661 with tax return |
| Ongoing reporting | Monthly milestone claims, progress reports, ITA check-ins | Annual — filed once with corporate tax return |
| Can be stacked? | Yes — they stack. Claim SR&ED on costs not covered by IRAP. | |
| Provincial component | No provincial equivalent (federal only) | Yes — provincial credits add 8% to 25% on top |
| Sole proprietors eligible? | No — must be incorporated | Technically yes (basic 15% rate only), but incorporation unlocks both programs |
| Total time to first dollar | 3-6 months (from first contact to first reimbursement) | 4-14 months (depends on filing timing and CRA review) |
Bottom line: IRAP wins on cash flow timing and advisory support. SR&ED wins on flexibility, total dollar ceiling, and lower application burden. For maximum R&D recovery, use both. The comparison table above is the single most important reference for any Canadian company evaluating innovation funding options.
The National Research Council's flagship program for technology-driven SMEs.
IRAP is not a form you fill out online and wait for a response. The process begins with a phone call to NRC (1-877-994-4727) or an online inquiry. NRC assigns you an Industrial Technology Advisor based on your region and technology domain. The ITA visits your business, assesses your innovation capacity, and helps shape your project proposal over 1-2 months.
Once your formal proposal is submitted, NRC reviews it internally. Processing times depend on the ask: under $50K averages 9 days, $50K-$500K averages 20 days, $500K-$3M averages 36 days. After approval, you receive a contribution agreement specifying milestones, eligible costs, and reporting requirements. You submit claims monthly as you hit milestones, and NRC reimburses the eligible portion.
The headline figure of "up to $1 million" (or even $10M for the largest projects) is misleading for most applicants. Here is what actually happens:
Understanding what IRAP excludes is as important as knowing what it funds. These costs are ineligible and must be covered through other sources or your own funds:
NRC does not publish rejection rates, but based on advisor community data, the most common rejection reasons are:
The ITA relationship is a critical factor that most comparison guides ignore. Your ITA does not just process paperwork — they provide ongoing technical and business advisory services, introduce you to potential collaborators, and help position future applications. Companies that build strong ITA relationships consistently receive larger awards over time. For a detailed walkthrough, see the complete IRAP funding guide.
Canada's largest single support program for business R&D — $4.5B annually.
The distinction between the enhanced and basic rate is the single most important factor in SR&ED economics. Canadian-controlled private corporations (CCPCs) receive the 35% enhanced rate on the first $6 million of qualified expenditures. This credit is fully refundable — you receive cash back even if your company owes zero taxes. Every other entity (public corporations, foreign-controlled companies, partnerships) receives only the 15% basic rate, which is non-refundable and can only reduce taxes owed.
The practical difference is enormous. A CCPC spending $1M on eligible R&D receives $350,000 in cash. A non-CCPC spending the same $1M receives a $150,000 credit that can only offset existing tax liability. If the non-CCPC has no tax liability, the credit carries forward but provides no immediate cash. This is why corporate structure matters more than most companies realize.
In addition to the federal credit, most provinces offer their own R&D tax credits that stack on top. Combined federal-plus-provincial rates range from 43% to approximately 55% in the most generous provinces. See the provincial top-ups table below for exact rates by province, or use the SR&ED calculator to model your specific scenario.
SR&ED covers a broader range of expenses than most companies realize. The eligible cost categories are:
Ineligible costs include marketing, market research, quality control, routine data collection, social science research, and style or aesthetic changes. The line between "routine development" and "R&D" is where most claim disputes occur. CRA scrutinizes whether the work involved genuine technological uncertainty or was simply applying known techniques in a standard way.
The CRA evaluates claims against three criteria: technological uncertainty (the solution was not achievable through standard practice), systematic investigation (you used a scientific or engineering methodology), and technological advancement (the work generated new knowledge). Routine development, quality control, market research, and style changes do not qualify. The most common rejection reason is claiming work that constitutes normal engineering rather than genuine R&D. For a complete filing walkthrough, see the SR&ED tax credit guide and the SR&ED claim guide.
The 2025 federal budget made the most significant changes to SR&ED in over a decade. IRAP was also affected indirectly.
Budget 2025 introduced three major changes to the SR&ED program that shift the economics significantly in favour of larger R&D spenders:
The doubled expenditure limit changes the stacking calculus. Previously, a company spending $4M on R&D would claim the 35% rate on $3M and the 15% rate on the remaining $1M. Now, the full $4M qualifies for the 35% rate. For companies that stack IRAP with SR&ED, this means the SR&ED credit on their co-investment portion is almost always at the enhanced 35% rate (since IRAP reduces the SR&ED expenditure pool, and most co-investment amounts fall well below $6M).
The capital equipment restoration is also relevant for IRAP recipients. IRAP does not cover capital equipment purchases — it only funds salary and subcontractor costs. Under the previous rules, companies could not claim SR&ED on the equipment either. Now, R&D-related capital equipment that IRAP does not fund can be included in the SR&ED claim at the 35% rate. This effectively closes a gap in the stacking strategy that previously left capital costs entirely unrecovered.
Budget 2025 made SR&ED substantially more valuable for CCPCs spending over $3M annually on R&D, and restored a critical benefit for hardware-intensive companies.
A CCPC spending $5M on R&D now receives $1.75M in federal enhanced credits (35% x $5M), versus $1.35M under the old rules (35% x $3M + 15% x $2M). That is $400,000 more per year. Companies with significant capital equipment expenditures gain an additional benefit that was unavailable since 2014.
Bad information costs Canadian companies millions in missed funding. Here are the facts.
"IRAP provides up to $1 million in funding."
Fact: While IRAP technically allows up to $10 million for large multi-year projects, the typical contribution is approximately $500,000. First-time applicants usually receive $75,000 to $200,000. Fewer than 10 awards per year across all of Canada exceed $1 million. The average per-firm contribution ranges from $94,000 to $168,000. Setting expectations at $1M leads to disappointment and poor project scoping.
Origin: NRC marketing materials cite the $10M ceiling. Consultants and blog posts round down to "$1M" as a headline figure without noting it represents the extreme top end.
"The SR&ED credit rate is 68%."
Fact: The federal enhanced rate is 35% for CCPCs on the first $6 million of eligible expenditures. The highest provincial credit (Manitoba) adds 20%, bringing the combined maximum to approximately 55%. The 68% figure does not correspond to any current published rate. It likely originated from a misunderstanding of how the proxy method overhead calculation interacts with credit rates, or from stacking now-defunct provincial incentive structures. In practice, most CCPC claimants recover 43% to 55% of eligible expenditures depending on province.
Origin: Outdated SR&ED consultant marketing materials and blog posts that have been copied across the web without verification against current CRA rates.
"IRAP and SR&ED are mutually exclusive — you have to choose one."
Fact: IRAP and SR&ED are explicitly designed to be complementary. NRC's own documentation states that IRAP-funded companies routinely claim SR&ED on their co-investment portion. The rule is straightforward: reduce your SR&ED expenditure pool by the amount of IRAP government assistance received, then claim SR&ED on the remainder. On a $500,000 R&D project where IRAP covers $300,000, you claim SR&ED on the remaining $200,000. Choosing one over the other leaves money on the table.
Origin: Confusion between "assistance stacking" (which is allowed, subject to the 75% cap) and "double dipping" (claiming the same dollar twice, which is not allowed).
"SR&ED requires pre-approval from the government before you start your R&D project."
Fact: SR&ED requires no pre-approval whatsoever. You perform the R&D, document it contemporaneously, and file your claim with your annual corporate tax return using Form T661. You have up to 18 months after your fiscal year-end to submit. There is no application to submit beforehand, no government advisor assigned, and no project proposal reviewed. This is the fundamental difference from IRAP, which does require pre-approval before eligible spending begins.
Origin: People who are familiar with IRAP's prospective approval process incorrectly assume SR&ED works the same way. The two programs operate on completely different timelines.
"Only technology companies qualify for IRAP and SR&ED."
Fact: Any Canadian business performing genuine R&D can qualify for SR&ED, regardless of industry. CRA evaluates the nature of the work (technological uncertainty, systematic investigation, technological advancement), not the industry. Manufacturing companies, food processors, construction firms, and mining companies regularly file successful SR&ED claims. IRAP has a somewhat narrower focus on technology innovation, but has funded projects in agriculture, clean energy, aerospace, and biotech — not just software.
Origin: The word "technology" in "Industrial Technology Advisor" and the prevalence of tech company case studies in NRC marketing create the impression that only tech companies apply.
A worked example with real numbers showing how combined recovery exceeds 60%.
The most powerful R&D funding strategy in Canada is not choosing between IRAP and SR&ED — it is using both on the same project. Here is exactly how the math works.
In this example, $500,000 of R&D work cost the company only $57,000 out of pocket after stacking both programs. The combined government recovery rate is 88.6%. Even accounting for the 75% government assistance cap (which applies to IRAP specifically, not to the stacked total in this manner), the economics are compelling.
To illustrate the value of stacking, consider the same $500,000 R&D project without IRAP:
The difference is stark. Stacking IRAP + SR&ED recovers $443,000 (88.6%). SR&ED alone recovers $215,000 (43%). The $228,000 difference represents the value of the IRAP application effort. For a project this size, the 3-6 month IRAP application process pays you approximately $228,000 for your time — a return on effort that few business activities can match.
Every incorporated Canadian SME doing genuine R&D should be claiming SR&ED annually as a baseline, and layering IRAP on top for major projects.
SR&ED costs nothing to apply for (no application fee, no pre-approval) and the 35% enhanced rate for CCPCs is one of the most generous R&D incentives in the world. Not claiming it is leaving cash on the table. IRAP adds upfront cash flow and strategic advisory for projects that warrant the application effort.
Definitive recommendations for six common business profiles.
Revenue: $0. Team: 3-5 engineers. Annual R&D: $200K-$400K. Needs cash now to extend runway.
Start with IRAP. The upfront cash and ITA advisory are survival-level resources. Claim SR&ED at year-end on your co-investment. Expected recovery: $200K-$350K combined.
Revenue: $10M+. Annual R&D: $500K-$2M. Improving production processes, developing new materials, automating quality control.
Lead with SR&ED. At $1M R&D spend, the 35% enhanced rate returns $350K with minimal application burden. Layer IRAP only for step-change innovation projects, not incremental improvements.
Revenue: $1M-$5M. Annual R&D: $800K-$3M. Building novel features, scaling infrastructure, integrating AI capabilities.
Claim SR&ED on all qualifying development work (more qualifies than you think). Apply for IRAP AI Assist ($100M stream) for your most ambitious AI/ML projects. Combined: $400K-$1.2M annually.
Revenue: $500K-$5M. Annual R&D: $500K-$2M. Prototyping, testing, regulatory compliance, materials science challenges.
Apply for both immediately. Hardware R&D is IRAP's sweet spot (strong technical uncertainty, clear milestones). Budget 2025 restored capital equipment as SR&ED-eligible, making hardware even more attractive. Combined: $400K-$1.5M annually.
Revenue: $2M-$8M. Develops internal tools, proprietary methodologies, or client-facing platforms.
SR&ED only. IRAP rarely funds consulting firms because the deliverable is typically a service, not a product. However, internal tool development and proprietary methodology creation can qualify for SR&ED if they involve genuine technological uncertainty. Expected: $50K-$200K annually.
Revenue: $0. Team: 2-5 researchers. Translating academic research into commercial product. May still have university lab access.
IRAP first, aggressively. University spinoffs with licensed IP are among IRAP's highest-priority candidates. The ITA will help bridge the "valley of death" between lab and market. Claim SR&ED on co-investment from day one. Also explore MITACS for graduate student funding.
Walk through these four questions to determine your strategy.
Are you incorporated in Canada?
No: You cannot access IRAP. You can claim SR&ED at the 15% basic rate as a sole proprietor, but you should seriously consider incorporating as a CCPC to unlock both programs and the 35% enhanced rate. Yes: Proceed to question 2.
Has your R&D work already started?
Yes, work is underway or complete: IRAP is not an option for this project (no retroactive funding). Claim SR&ED on eligible expenditures within 18 months of fiscal year-end. Apply for IRAP on your next project. No, work has not started: Apply for IRAP now, before spending begins. Plan to claim SR&ED later on your co-investment. Proceed to question 3.
Is your annual R&D budget above $300,000?
Under $300K: SR&ED alone returns $105K at the 35% rate, which may be sufficient. IRAP application effort is significant — weigh the time cost against the expected award. Over $300K: Apply for both. IRAP provides upfront cash flow that SR&ED cannot. The larger your R&D budget, the more valuable IRAP becomes as a cash flow tool.
Do you have the internal capacity to manage IRAP reporting?
No — lean team, no grant experience: Start with SR&ED (lower overhead, annual filing only). Build documentation habits. Apply for IRAP once you have a grant-management rhythm. Yes — experienced team or willing to invest: Apply for IRAP immediately. The monthly milestone reporting is manageable and the ITA support compensates for the effort. Stack SR&ED at year-end.
If you answered "yes" to all four questions, apply for IRAP today and plan your SR&ED claim at fiscal year-end. That is the optimal Canadian R&D funding strategy, full stop.
Over a 3-year horizon, a CCPC spending $500K/year on R&D that stacks both programs recovers approximately $1.3M in combined funding. A company using SR&ED alone recovers approximately $525K over the same period. The IRAP application effort pays for itself many times over.
From first action to first dollar received.
Cash flow summary: IRAP delivers first reimbursement approximately 5-6 months after initial contact, with monthly payments thereafter. SR&ED delivers a lump sum 4-14 months after your fiscal year-end. For companies with cash flow constraints, IRAP's monthly reimbursement model is significantly better than waiting for an annual SR&ED refund.
Federal credits are just the beginning. Provincial credits add 8% to 25% on top.
| Province | Provincial R&D Credit Rate | Refundable? | Combined with Federal (CCPC) |
|---|---|---|---|
| Ontario | 8% (OITC) + 3.5% (ORDTC) | OITC: Yes; ORDTC: No | ~46.5% |
| Quebec | 14% | Yes | ~49% |
| British Columbia | 10% | Yes (for CCPCs) | ~45% |
| Alberta | 8% (ASRIP) | Yes | ~43% |
| Manitoba | 20% | Yes | ~55% |
| Saskatchewan | 10% | No | ~45% |
| New Brunswick | 15% | Yes | ~50% |
| Nova Scotia | 15% | Yes | ~50% |
| Newfoundland & Labrador | 15% | Yes | ~50% |
| Prince Edward Island | No provincial credit | N/A | 35% |
| Territories (YT, NT, NU) | No territorial credit | N/A | 35% |
Highest combined rate: Manitoba at approximately 55% (35% federal enhanced + 20% provincial). Lowest: PEI and the territories at 35% (federal only). These rates apply to CCPC expenditures within the $6M threshold. For a personalized estimate with your province and R&D spend, use the SR&ED calculator.
Manitoba and New Brunswick are the most financially advantageous provinces in Canada for R&D tax credits, not Ontario or Quebec as most people assume.
Manitoba's 20% refundable provincial credit plus the 35% federal enhanced rate delivers ~55% recovery on eligible R&D expenditures. Ontario's combined rate (~46.5%) is lower, though Ontario's larger innovation ecosystem provides non-financial advantages. Quebec (49%) is competitive but adds administrative complexity through Revenu Quebec's separate filing process.
Official government sources used in this comparison.
10 questions we hear most often about IRAP vs SR&ED.
IRAP stream openings, SR&ED deadline reminders, Budget changes, and new program launches — delivered to your inbox.